Mahadevia Ankit
CIK 0001720974
CEO and PresidentDirector
Filings
11
Latest Sep 3, 2025
Issuers covered
1
Showing
11 of 11
Page 1
Track record
7 of 7 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 7 | 86% | +6.4% | +7.2% | +20.0% | -14.8% |
| 90 days | 7 | 71% | +9.0% | +7.1% | +32.7% | -16.5% |
| 180 days | 7 | 43% | -40.3% | -11.5% | +41.7% | -157.7% |
| 365 days | 6 | 33% | -51.4% | -26.5% | +44.8% | -162.3% |
Issuers
Companies where Mahadevia Ankit has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| SPRO | Spero Therapeutics, Inc. | 11 | Sep 3, 2025 |
All filings
11 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|